Tenaya Therapeutics, Inc. Accumulated Other Comprehensive Income
Tenaya Therapeutics, Inc. (TNYA) had Accumulated Other Comprehensive Income of $0 as of 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-03-11
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.00K.
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$10.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $28.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-11 |
| 2025-06-30 | -$1.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | -$10.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $28.00K 10-K · filed 2026-03-11 |
| 2024-09-30 | $76.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | -$67.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$120.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$106.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | -$261.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$333.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$120.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$378.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | -$767.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$739.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$631.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$141.00K 10-K · filed 2023-03-08 |
| 2021-09-30 | -$23.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |